India to Germany: Oxaliplatin Export Trade Route

The India to Germany Oxaliplatin corridor is one of India's established pharmaceutical export routes, with 362 shipments documented worth a combined $10.0M USD. The route is dominated by FRESENIUS KABI ONCOLOGY LIMITED, which alone accounts for roughly 79% of all export value, reflecting the consolidated nature of India's oxaliplatin manufacturing sector.

Across 2 active suppliers, the average shipment value stands at $27.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 82% of all shipments, consistent with oxaliplatin's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 31 days port-to-port. The route has recorded an annual growth rate of 31.4%, placing it at rank #7 among India's top oxaliplatin export destinations globally.

On the import side, key buyers of Indian oxaliplatin in Germany include FRESENIUS KABI DEUTSCHLAND GMBH, FRESENIUS KABI DEUTSCHLAND GMBH . FRESENIUS KABI DEUTSCHLAND GMBH is the single largest importer with 273 shipments valued at $7.9M USD.

India's oxaliplatin exports to Germany are driven primarily by a handful of large-scale manufacturers. FRESENIUS KABI ONCOLOGY LIMITED with 273 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Germany benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — FRESENIUS KABI ONCOLOGY LIMITED, FRESENIUS KABI ONCOLOGY LIMITED — together account for 100% of total trade value on this route. The average shipment value of $27.7K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as oxaliplatin kabi inj.200mg/40ml vial(ite and oxaliplatine fresenius kabi inj.200mg/40 , suggesting that buyers in Germany tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, FRESENIUS KABI DEUTSCHLAND GMBH is the largest importer with 273 shipments worth $7.9M USD — representing 79% of all oxaliplatin imports from India on this route.